We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+10.32%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$524M
Cap. Flow
% of AUM
386.8%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$13M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$8.2M |
| 3 |
CELG
Celgene Corp
CELG
|
+$6.34M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
+$5.55M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
+$5.42M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.09% |
| 2 | Consumer Discretionary | 6.1% |
| 3 | Materials | 3.81% |
| 4 | Consumer Staples | 3.68% |
| 5 | Technology | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMP
26
DELISTED
Cempra, Inc.
CEMP
| $1.55M | 1.14% |
+49,672
| New | +$1.38M |
|
27
GE Aerospace
GE
$361B
| $1.53M | 1.13% |
+10,238
| New | +$1.45M |
|
28
Amgen
AMGN
$201B
| $1.53M | 1.13% |
+9,400
| New | +$1.48M |
|
|
CMRX
29
DELISTED
Chimerix, Inc.
CMRX
| $1.38M | 1.02% |
+154,100
| New | +$5.55M |
|
30
Cal-Maine
CALM
$4.18B
| $1.35M | 0.99% |
+29,054
| New | +$1.56M |
|
31
Coca-Cola Europacific Partners
CCEP
$46.9B
| $1.21M | 0.89% |
+24,600
| New | +$1.24M |
|
|
GWPH
32
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.19M | 0.88% |
+51,300
| New | +$4.18M |
|
|
DVAX
33
DELISTED
Dynavax Technologies
DVAX
| $1.14M | 0.84% |
+47,248
| New | +$1.18M |
|
|
YHOO
34
DELISTED
Yahoo Inc
YHOO
| $1.12M | 0.83% |
+33,741
| New | +$1.13M |
|
35
Synchrony
SYF
$25B
| $1.1M | 0.81% |
+36,033
| New | +$1.13M |
|
|
ALXN
36
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.08M | 0.8% |
+5,687
| New | +$993K |
|
37
AT&T
T
$153B
| $1.03M | 0.76% |
+39,581
| New | +$1M |
|
38
CALL
Pacira BioSciences
PCRX
$1.01B
| $971K | 0.72% |
+54,400
| New | +$3.08M |
|
39
Broadcom
AVGO
$1.78T
| $962K | 0.71% |
+66,260
| New | +$861K |
|
40
PUT
Bausch Health
BHC
$1.84B
| $961K | 0.71% |
+88,700
| New | +$9.97M |
|
41
Insperity
NSP
$1.89B
| $932K | 0.69% |
+38,708
| New | +$878K |
|
42
PUT
DuPont de Nemours
DD
$18.1B
| $923K | 0.68% |
+19,744
| New | +$2.53M |
|
|
LUMO
43
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $920K | 0.68% |
+7,978
| New | +$2.6M |
|
44
PUT
GameStop
GME
$9.84B
| $875K | 0.65% |
+312,400
| New | +$3.02M |
|
|
45
PUT
Gilead Sciences
GILD
$169B
| $840K | 0.62% |
+303,000
| New | +$31.5M |
|
|
SYT
46
DELISTED
Syngenta Ag
SYT
| $810K | 0.6% |
+10,294
| New | +$736K |
|
|
HOT
47
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $797K | 0.59% |
+11,500
| New | +$821K |
|
48
PUT
Viatris
VTRS
$20.2B
| $740K | 0.55% |
+47,500
| New | +$2.28M |
|
49
Precigen
PGEN
$1.76B
| $725K | 0.53% |
+24,265
| New | +$818K |
|
50
PUT
MannKind Corp
MNKD
$1.25B
| $699K | 0.52% |
+50,000
| New | +$615K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q4 2015 Portfolio in Review
Q4 2015 is the first quarter with a 13F filing on record for FT Options, which disclosed 204 positions worth $136M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is Gilead Sciences: 125,233 shares worth $12.7M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Materials.
- FT Options's largest Q4 2015 buy was Gilead Sciences: 125,233 shares worth $12.7M.
- FT Options's ten largest holdings make up 40% of its $136M portfolio in Q4 2015.
- FT Options disclosed 204 positions in Q4 2015, its first 13F filing on record.
Based on FT Options's 13F filing for Q4 2015, filed 5 Feb 2016.